Breakthroughs that Change Patients’ Lives
Pfizer Taiwan’s latest national honors highlight its continued role in advancing vaccine innovation, oncology treatment, and Taiwan’s broader public health resilience.
The Systems Behind Trust at Herbalife
Herbalife Taiwan is building trust through transparent regulatory engagement, distributor education, and compliance systems spanning product quality, ethics, and consumer protection.
Novartis and Taiwan Advance a New ASCVD Framework
Novartis Taiwan is working with NHIA, medical societies, and healthcare partners to strengthen ASCVD prevention and care through clearer clinical pathways, earlier follow-up, and more consistent cholesterol management. The initiative reflects Taiwan’s growing focus on practical, cross-sector approaches to chronic disease management under the Healthy Taiwan vision.
Johnson & Johnson Connects Innovation to Patient Access for a Healthier Taiwan
Johnson & Johnson Taiwan is advancing patient access, precision diagnosis, and coordinated care to support the Healthy Taiwan vision and help more patients benefit from innovation earlier.
Novo Nordisk Taiwan and the Shift From Weight Loss to Long-Term Health
Novo Nordisk Taiwan is reframing obesity from weight loss to long-term health, emphasizing prevention, early intervention, and collaboration across Taiwan’s healthcare system. Through awareness, screening, and employee support, the company is helping advance a broader approach to metabolic health.
Coupang Accelerates Investments to Drive Growth in Taiwan
Coupang is expanding its long-term investments in Taiwan, using AI-driven logistics and digital retail capabilities to improve speed, service, and customer experience. As one of Coupang’s key growth markets, Taiwan is also positioned to support deeper U.S.-Taiwan economic ties and broader digital innovation across Asia.
Moderna in Taiwan: Building an mRNA Innovation Ecosystem
Moderna Taiwan is advancing mRNA science, partnerships, and local talent development to support healthcare innovation and long-term health preparedness in Taiwan.
Reframing Hepatitis B: Taiwan’s Next Phase of Liver Disease Control
Taiwan has made major progress in hepatitis prevention, but chronic hepatitis B continues to drive a significant share of liver cancer cases. As new therapies, earlier intervention, and more targeted screening reshape care, stronger policy support could help Taiwan move toward the next phase of liver disease control.
Where Chronic Care Is Headed: Bayer Taiwan’s Innovation Pipeline
Bayer Taiwan’s innovation pipeline reflects a broader shift in chronic care, with earlier intervention, longer-lasting treatments, and improved access helping patients manage disease more sustainably over time.
AstraZeneca: Building a System for the Next Generation of Care
Taiwan has built a strong reputation for broad access to innovative medicines, but the next wave of precision therapies and diagnostics will require more adaptive assessment, reimbursement, and funding pathways.